You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Insulin degludec, insulin aspart drug combination

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes Trial (Insulin Degludec and Insulin Aspart)

Not yet recruiting
  • Diabetes
  • Insulin Degludec and Insulin Aspart
  • (no location specified)
Apr 4, 2023

Type 2 Diabetes Trial in China (Insulin Degludec and Insulin Aspart Injection, Insulin Aspart Injection)

Not yet recruiting
  • Type 2 Diabetes Mellitus
  • Insulin Degludec and Insulin Aspart Injection
  • Insulin Aspart Injection
  • Shijiazhuang, Hebei, China
  • +5 more
Jun 13, 2022

Diabetes, Type 1, Diabetes, Type 2 Trial in China (Faster aspart, Insulin aspart, Insulin degludec)

Completed
  • Diabetes Mellitus, Type 1
  • Diabetes Mellitus, Type 2
  • Faster aspart
  • +2 more
  • Hefei, Anhui, China
  • +34 more
Nov 3, 2022

Liver Cirrhosis, Diabetes Trial in Shanghai (Insulin Degludec and Insulin Aspart)

Recruiting
  • Liver Cirrhosis
  • Diabetes
  • Insulin Degludec and Insulin Aspart
  • Shanghai, Shanghai, China
    Xiaolong Zhao
Nov 29, 2022

Diabetes, Type 2 Treated With Insulin Trial in Bogotá (insulin degludec + liraglutide, Insulin Glargine - Insulin Aspart)

Recruiting
  • Diabetes Mellitus, Type 2 Treated With Insulin
  • insulin degludec + liraglutide
  • Insulin Glargine - Insulin Aspart
  • Bogotá, Colombia
    Hospital Universitario San Ignacio
Mar 2, 2023

Type 2 Diabetes Trial in Cleveland (Semaglutide, Insulin Degludec, Insulin aspart)

Recruiting
  • Type 2 Diabetes
  • Cleveland, Ohio
    Cleveland Clinic
Jul 18, 2022

Diabetes, Type 1 Trial in Worldwide (insulin icodec, insulin degludec, insulin aspart)

Completed
  • Diabetes Mellitus, Type 1
  • insulin icodec
  • +2 more
  • Concord, California
  • +98 more
Feb 2, 2023

Diabetes, Diabetic Kidney Disease Trial in Sha Tin (Dulaglutide, Insulin Degludec, Continuous glucose monitor)

Recruiting
  • Diabetes Mellitus
  • Diabetic Kidney Disease
  • Sha Tin, Hong Kong
    Prince of Wales Hospital
Nov 8, 2022

Ryzodeg® inReal-world Adult Population With Type 2 Diabetes in

Completed
  • Diabetes Mellitus, Type 2
  • Daejeon, Korea, Republic of
  • +5 more
Sep 27, 2021

Type 1 Diabetes Trial in Aurora (Multiple daily ijnection using Insulin Degludec and Insulin Aspart)

Completed
Has Results
  • Type 1 Diabetes
  • Multiple daily ijnection using Insulin Degludec and Insulin Aspart
  • Aurora, Colorado
    Barbara Davis Center for Diabetes
Sep 9, 2021

Type 1 Diabetes Trial in Loma Linda, Austin (Afrezza (insulin human) Inhalation Powder, insulin degludec, Continuous

Recruiting
  • Type 1 Diabetes
  • Afrezza (insulin human) Inhalation Powder
  • +2 more
  • Loma Linda, California
  • +1 more
Apr 12, 2022

Type 1 Diabetes With Diabetic Gastroparesis, HbA1c, Time in Range Trial in Hangzhou (insulin degludec/insulin aspart (IDegAsp),

Recruiting
  • Type 1 Diabetes Mellitus With Diabetic Gastroparesis
  • +2 more
  • insulin degludec/insulin aspart (IDegAsp)
  • basal insulin plus pre-prandial insulin
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jul 7, 2021

Type 2 Diabetes Trial in Atlanta, New York, Spokane (Degludec, Glargine, Aspart)

Completed
Has Results
  • Type 2 Diabetes
  • Atlanta, Georgia
  • +3 more
Mar 25, 2022

Type1 Diabetes Trial in Asheville (Aspart)

Completed
  • Type1 Diabetes Mellitus
  • Asheville, North Carolina
    Mountain Diabetes and Endocrine Center
Feb 23, 2021

Diabetes, Diabetes, Type 1 Trial in Worldwide (Insulin degludec, Insulin Aspart, Insulin detemir)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 1
  • Insulin degludec
  • +2 more
  • Caba, Argentina
  • +70 more
Mar 29, 2022

Looking at How Ryzodeg® Works in People With Type 2 Diabetes in

Recruiting
  • Diabetes Mellitus, Type 2
  • Hefei, Anhui, China
  • +50 more
Feb 2, 2023

NovoPen® 6 for Treatment With Tresiba® & Fiasp® Affects Blood

Enrolling by invitation
  • Diabetes Mellitus, Type 1
  • Insulin degludec
  • Fast-acting insulin aspart
  • Bonheiden, Belgium
  • +22 more
Dec 19, 2022

Diabetes, Type 2 Trial in Worldwide (Insulin icodec, Placebo insulin icodec, Insulin degludec)

Completed
  • Diabetes Mellitus, Type 2
  • Insulin icodec
  • +3 more
  • Guntersville, Alabama
  • +91 more
Nov 11, 2022

Ryzodeg® in Adult Patients With Type 2 Diabetes in Lebanon

Enrolling by invitation
  • Diabetes Mellitus, Type 2
  • Insulin Degludec/Insulin Aspart
  • Beirut, Hamra, Beirut, Lebanon
    Novo Nordisk Investigational Site
Sep 30, 2021

Type2 Diabetes Trial in Roma (IDegLira)

Completed
  • Type2 Diabetes
  • Roma, Italy
    Stefano Rizza
Aug 2, 2021

Type 2 Diabetes Trial in China (INSULIN GLARGINE (HOE901), Insulin Glulisine, Biphasic insulin aspart 30)

Completed
  • Type 2 Diabetes Mellitus
  • INSULIN GLARGINE (HOE901)
  • +5 more
  • China, China
    CHINA
Apr 21, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (Faster-acting insulin aspart, Insulin aspart, Insulin degludec)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Faster-acting insulin aspart
  • +3 more
  • Concord, California
  • +166 more
Jan 6, 2022

Type 1 Diabetes Trial in Argentina, China, Mexico (LY900014, Insulin Lispro, Insulin Glargine)

Completed
  • Type 1 Diabetes Mellitus
  • Caba, Buenos Aires, Argentina
  • +29 more
Feb 18, 2022

(rPMS) Study of Ryzodeg® FlexTouch® to Evaluate Safety and

Completed
  • Diabetes
  • +2 more
  • Insulin degludec /insulin aspart
  • Busan, Korea, Republic of
  • +26 more
Nov 9, 2021

Hyperkalemia Trial in France (Salbutamol, Insulin Aspart)

Recruiting
  • Hyperkalemia
  • Agen, France
  • +15 more
Feb 4, 2022